Literature DB >> 3045071

Malignant tumor cell lines produce interleukin-1-like factor.

S Miyauchi1, T Moroyama, S Kyoizumi, J Asakawa, T Okamoto, K Takada.   

Abstract

Sixty-four malignant cell lines were examined for interleukin-1 (IL-1) activities in their conditioned medium using thymocyte and fibroblast proliferation assays. Sixteen cell lines showed high IL-1 activity. Comparison of these activities with human IL-1 showed similarity between some biological properties. However there was no correlation between cell origin and IL-1 activity. These results suggest the possibility that most malignant cells may produce an IL-1-like factor.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3045071     DOI： 10.1007/BF02623644

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol        ISSN： 0883-8364


  25 in total

1.  Pure brain-derived acidic fibroblast growth factor is a potent angiogenic vascular endothelial cell mitogen with sequence homology to interleukin 1.

Authors:  K A Thomas; M Rios-Candelore; G Giménez-Gallego; J DiSalvo; C Bennett; J Rodkey; S Fitzpatrick
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

2.  Purification and characterization of heparin-binding endothelial cell growth factors.

Authors:  R Lobb; J Sasse; R Sullivan; Y Shing; P D'Amore; J Jacobs; M Klagsbrun
Journal:  J Biol Chem       Date:  1986-02-05       Impact factor: 5.157

3.  Basic fibroblast growth factor fused to a signal peptide transforms cells.

Authors:  S Rogelj; R A Weinberg; P Fanning; M Klagsbrun
Journal:  Nature       Date:  1988-01-14       Impact factor: 49.962

4.  Corneal epithelial cell--derived thymocyte-activating factor (CETAF).

Authors:  G Grabner; T A Luger; G Smolin; J J Oppenheim
Journal:  Invest Ophthalmol Vis Sci       Date:  1982-12       Impact factor: 4.799

5.  Interleukin 1 is present in normal human epidermis.

Authors:  C Hauser; J H Saurat; A Schmitt; F Jaunin; J M Dayer
Journal:  J Immunol       Date:  1986-05-01       Impact factor: 5.422

Review 6.  Interleukin-1.

Authors:  C A Dinarello
Journal:  Rev Infect Dis       Date:  1984 Jan-Feb

7.  Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects.

Authors:  A Fontana; H Hengartner; N de Tribolet; E Weber
Journal:  J Immunol       Date:  1984-04       Impact factor: 5.422

8.  The effect of calcium-regulating hormones and prostaglandins on bone resorption by osteoclasts disaggregated from neonatal rabbit bones.

Authors:  T J Chambers; P M McSheehy; B M Thomson; K Fuller
Journal:  Endocrinology       Date:  1985-01       Impact factor: 4.736

9.  Interleukin 1 stimulation of collagenase production by cultured fibroblasts.

Authors:  A E Postlethwaite; L B Lachman; C L Mainardi; A H Kang
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

10.  Detection and characterization of high affinity plasma membrane receptors for human interleukin 1.

Authors:  S K Dower; S R Kronheim; C J March; P J Conlon; T P Hopp; S Gillis; D L Urdal
Journal:  J Exp Med       Date:  1985-08-01       Impact factor: 14.307
View more
  7 in total

1.  Mutations in the human homologue of the Drosophila segment polarity gene patched in oral squamous cell carcinoma cell lines.

Authors:  E Michimukai; N Kitamura; Y Zhang; H Wang; Y Hiraishi; K Sumi; Y Hayashido; S Toratani; T Okamoto
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001 Jul-Aug       Impact factor: 2.416

2.  Eldecalcitol (ED-71), an analog of 1α,25(OH)2D3, inhibits the growth of squamous cell carcinoma (SCC) cells in vitro and in vivo by down-regulating expression of heparin-binding protein 17/fibroblast growth factor-binding protein-1 (HBp17/FGFBP-1) and FGF-2.

Authors:  T Shintani; F Takatsu; S N Z Rosli; E Usui; A Hamada; K Sumi; Y Hayashido; S Toratani; Tetsuji Okamoto
Journal:  In Vitro Cell Dev Biol Anim       Date:  2017-07-14       Impact factor: 2.416

3.  Expression of fibroblast growth factor binding protein HBp17 in normal and tumor cells.

Authors:  T Okamoto; Y Tanaka; M Kan; A Sakamoto; K Takada; J D Sato
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-02       Impact factor: 2.416

4.  1α,25(OH)₂D₃ inhibits FGF-2 release from oral squamous cell carcinoma cells through down-regulation of HBp17/FGFBP-1.

Authors:  S N Zawani B Rosli; Tomoaki Shintani; Shigeaki Toratani; Emiko Usui; Tetsuji Okamoto
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-06-18       Impact factor: 2.416

5.  Cytotoxic Effect of the Genus Sinularia Extracts on Human SCC25 and HaCaT Cells.

Authors:  Guey-Horng Wang; Tzung-Han Chou; Rong-Jyh Lin; Jyh-Horng Sheu; Shih-Hao Wang; Chia-Hua Liang
Journal:  J Toxicol       Date:  2008-10-13

6.  Release of fibroblast growth factor-1 by human squamous cell carcinoma correlates with autocrine cell growth.

Authors:  Y Myoken; Y Myoken; T Okamoto; M Kan; J D Sato; K Takada
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-11       Impact factor: 2.416

7.  Extracts from Cladiella australis, Clavularia viridis and Klyxum simplex (soft corals) are capable of inhibiting the growth of human oral squamous cell carcinoma cells.

Authors:  Chia-Hua Liang; Guey-Horng Wang; Chih-Chuang Liaw; Mei-Feng Lee; Shih-Hao Wang; Da-Long Cheng; Tzung-Han Chou
Journal:  Mar Drugs       Date:  2008-11-03       Impact factor: 5.118
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.